Gene expression profiling in autoimmune diseases: Chronic inflammation or disease specific patterns?

References

• Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 2005; 38: 247–255
   PubMed Web of Science ®Google Scholar
• Baechler EC, Batliwalla FM, Reed AM, Peterson EJ, Gaffney PM, Moser KL, Gregersen PK, Behrens TW. Gene expression profiling in human autoimmunity. Immunol Rev 2006; 210: 120–137
   PubMed Web of Science ®Google Scholar
• Bovin LF, Rieneck K, Workman C, Nielsen H, Sorensen SF, Skjodt H, Florescu A, Brunak S, Bendtzen K. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol Lett 2004; 93: 217–226
   PubMedGoogle Scholar
• Gu J, Marker-Hermann E, Baeten D, Tsai WC, Gladman D, Xiong M, Deister H, Kuipers JG, Huang F, Song YW, Maksymowych W, Kalsi J, Bannai M, Seta N, Rihl M, Crofford LJ, Veys E, De Keyser F, Yu DT. A 588-gene micro array analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002; 41: 759–766
   PubMed Web of Science ®Google Scholar
• Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM. Cutting edge: Molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5–9
   PubMed Web of Science ®Google Scholar
• Batliwalla FM, Baechler EC, Xiao X, Li W, Balasubramanian S, Khalili H, Damle A, Ortmann WA, Perrone A, Kantor AB, Gulko PS, Kern M, Furie R, Behrens TW, Gregersen PK. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun 2005; 6: 388–397
   PubMed Web of Science ®Google Scholar
• Rus V, Atamas SP, Shustova V, Luzina IG, Selaru F, Magder LS, Via CS. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283–290
   PubMed Web of Science ®Google Scholar
• Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610–2615
   PubMed Web of Science ®Google Scholar
• Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711–723
   PubMed Web of Science ®Google Scholar
• Bomprezzi R, Ringner M, Kim S, Bittner ML, Khan J, Chen Y, Elkahloun A, Yu A, Bielekova B, Meltzer PS, Martin R, McFarland HF, Trent JM. Gene expression profile in multiple sclerosis patients and healthy controls: Identifying pathways relevant to disease. Hum Mol Genet 2003; 12: 2191–2199
   PubMed Web of Science ®Google Scholar
• Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A. Autoimmunity gene expression portrait: Specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin Exp Immunol 2004; 138: 164–170
   PubMed Web of Science ®Google Scholar
• Koczan D, Guthke R, Thiesen HJ, Ibrahim SM, Kundt G, Krentz H, Gross G, Kunz M. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 2005; 15: 251–257
   Web of Science ®Google Scholar
• Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: A unifying hypothesis. Clin Endocrinol (Oxf) 2004; 60: 397–409
   PubMed Web of Science ®Google Scholar
• Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99–107
   PubMed Web of Science ®Google Scholar
• Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004; 71: 275–283
   PubMed Web of Science ®Google Scholar
• Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001; 36: 2–15
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–429
   PubMed Web of Science ®Google Scholar
• Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. JAMA 1984; 251: 73–79, By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”?. World J Gastroenterol 2006; 12: 1829–1841
   PubMed Web of Science ®Google Scholar
• Winther KV, Fogh P, Thomsen OO, Brynskov J. Inflammatory bowel disease (ulcerative colitis and Crohn's disease): Diagnostic criteria and differential diagnosis. Drugs Today (Barc) 1998; 34: 935–942
   PubMedGoogle Scholar
• Aune TM, Maas K, Moore JH, Olsen NJ. Gene expression profiles in human autoimmune disease. Curr Pharm Des 2003; 9: 1905–1917
   PubMedGoogle Scholar
• Stenson WF. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol Suppl 1990; 172: 13–18
   PubMedGoogle Scholar
• Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 1995; 10: 387–395
   PubMed Web of Science ®Google Scholar
• Lugering N, Kucharzik T, Stoll R, Domschke W. A system of nonspecific defense in chronic inflammatory bowel diseases—pathophysiologic and therapeutic aspects. Z Gastroenterol 1998; 36: 173–187
   PubMedGoogle Scholar
• Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H, Kanai T, Hibi T. Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis. Cancer Res 1999; 59: 5927–5931
   PubMed Web of Science ®Google Scholar
• Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000; 4: 1–11
   PubMed Web of Science ®Google Scholar
• Thunnissen MM, Nordlund P, Haeggstrom JZ. Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation. Nat Struct Biol 2001; 8: 131–135
   PubMedGoogle Scholar
• Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Crohn's disease: A defensin deficiency syndrome?. Eur J Gastroenterol Hepatol 2003; 15: 627–634
   PubMed Web of Science ®Google Scholar
• Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003; 52: 847–853
   PubMed Web of Science ®Google Scholar
• Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner BL, Phillips SF. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997; 72: 117–123
   PubMed Web of Science ®Google Scholar
• Saitoh O, Matsumoto H, Sugimori K, Sugi K, Nakagawa K, Miyoshi H, Hirata I, Matsuse R, Uchida K, Ohshiba S. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases. Digestion 1995; 56: 67–75
   PubMed Web of Science ®Google Scholar
• Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: Comparison with other neutrophil-derived proteins. Am J Gastroenterol 1996; 91: 927–934
   PubMed Web of Science ®Google Scholar
• Aadland E, Fagerhol MK. Faecal calprotectin: A marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002; 14: 823–825
   PubMed Web of Science ®Google Scholar
• Summerton CB, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: A marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002; 14: 841–845
   PubMed Web of Science ®Google Scholar
• Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: A new parameter to monitor infliximab therapy. Dig Dis Sci 2004; 49: 1036–1039
   PubMed Web of Science ®Google Scholar
• Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, Casciotti L, Maganti V, Reddy PS, Strahs A, Immermann F, Spinelli W, Schwertschlag U, Slager AM, Cotreau MM, Dorner AJ. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn 2006; 8: 51–61
   PubMed Web of Science ®Google Scholar
• Gordon T, Isenberg D. The endocrinologic associations of the autoimmune rheumatic diseases. Semin Arthritis Rheum 1987; 17: 58–70
   PubMed Web of Science ®Google Scholar
• McLean RM, Podell DN. Bone and joint manifestations of hypothyroidism. Semin Arthritis Rheum 1995; 24: 282–290
   PubMedGoogle Scholar
• Autschbach F, Giese T, Gassler N, Sido B, Heuschen G, Heuschen U, Zuna I, Schulz P, Weckauf H, Berger I, Otto HF, Meuer SC. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 2002; 441: 500–513
   PubMedGoogle Scholar
• Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut 1998; 43: 210–215
   PubMedGoogle Scholar
• Chen X, Wang S, Wu N, Yang CS. Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Curr Cancer Drug Targets 2004; 4: 267–283
   PubMed Web of Science ®Google Scholar
• Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: Comparison with other neutrophil-derived proteins. Am J Gastroenterol 1996; 91: 927–934
   PubMed Web of Science ®Google Scholar
• Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: Results from the Norfolk arthritis register study, a large inception cohort. Arthritis Rheum 2002; 46: 906–912
   PubMed Web of Science ®Google Scholar
• Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 628–637
   PubMed Web of Science ®Google Scholar
• Madland TM, Hordvik M, Haga HJ, Jonsson R, Brun JG. Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scand J Rheumatol 2002; 31: 351–354
   PubMed Web of Science ®Google Scholar
• Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001; 69: 986–994
   PubMed Web of Science ®Google Scholar